WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Wettan Keeley M. CainEVP2026-08-102,908$133.06
$386.94kSell
Daniel Patrick OdayCEO;Chair2026-08-037,700$130.80
$1.01MSell
Daniel Patrick OdayCEO;Chair2026-08-03600$131.34
$78.81kSell
Daniel Patrick OdayCEO;Chair2026-08-036,700$129.66
$868.71kSell
Andrew D. DickinsonCFO2026-07-153,000$129.93
$389.78kSell
Johanna MercierChief2026-07-153,000$129.92
$389.76kSell
Daniel Patrick OdayChairman CEO2026-07-0111,900$126.09
$1.50MSell
Daniel Patrick OdayChairman CEO2026-07-013,100$127.08
$393.93kSell
Johanna MercierChief Comm Corp Aff Officer2026-06-15450$125.40
$56.43kSell
Andrew D. DickinsonChief Financial Officer2026-06-153,000$125.40
$376.20kSell

1 of 10

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John C. Martin0.29%3,619,142$500.74MInsider
Norbert W. Bischofberger0.19%2,393,196$331.12MInsider
Assenagon Asset Management Sa0.18%2,287,888$316.55MInstitution
Gordon Earle Moore0.15%1,917,337$265.28MInsider
Swedbank Ab0.15%1,903,177$263.32MInstitution
John F. Milligan0.14%1,797,816$248.75MInsider
Handelsbanken Fonder Ab0.08%975,089$134.91MInstitution
Etienne Davignon0.07%838,652$116.04MInsider
Confluence Investment Management LLC0.07%832,632$115.20MInstitution
Wealth Enhancement Advisory Services LLC0.05%603,836$83.55MInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD0.09%1.11%Net SellingNet Selling
PFE0.07%0.27%Net BuyingNet Buying
BMY0.08%0.37%Net SellingNet Selling
AMGN0.08%1.01%Net SellingNet Selling
SNY0.02%0.00%
View Top General Drug Manufacturer Stocks

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 0.09% institutional shareholders, 1.11% Gilead Sciences insiders, and 98.80% retail investors. John C. Martin is the largest individual Gilead Sciences shareholder, owning 3.62M shares representing 0.29% of the company. John C. Martin's Gilead Sciences shares are currently valued at $500.74M.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.